A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor Oseltamivir from 1,3-butadiene and acrylic acid
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yeung, YY | ko |
| dc.contributor.author | Hong, Sungwoo | ko |
| dc.contributor.author | Corey, EJ | ko |
| dc.date.accessioned | 2013-03-06T09:14:54Z | - |
| dc.date.available | 2013-03-06T09:14:54Z | - |
| dc.date.created | 2012-02-06 | - |
| dc.date.created | 2012-02-06 | - |
| dc.date.issued | 2006-05 | - |
| dc.identifier.citation | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, v.128, no.19, pp.6310 - 6311 | - |
| dc.identifier.issn | 0002-7863 | - |
| dc.identifier.uri | http://hdl.handle.net/10203/86524 | - |
| dc.language | English | - |
| dc.publisher | AMER CHEMICAL SOC | - |
| dc.subject | NEURAMINIDASE INHIBITORS | - |
| dc.subject | INFLUENZA | - |
| dc.title | A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor Oseltamivir from 1,3-butadiene and acrylic acid | - |
| dc.type | Article | - |
| dc.identifier.wosid | 000237590400021 | - |
| dc.identifier.scopusid | 2-s2.0-33646567839 | - |
| dc.type.rims | ART | - |
| dc.citation.volume | 128 | - |
| dc.citation.issue | 19 | - |
| dc.citation.beginningpage | 6310 | - |
| dc.citation.endingpage | 6311 | - |
| dc.citation.publicationname | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | - |
| dc.identifier.doi | 10.1021/ja0616433 | - |
| dc.contributor.localauthor | Hong, Sungwoo | - |
| dc.contributor.nonIdAuthor | Yeung, YY | - |
| dc.contributor.nonIdAuthor | Corey, EJ | - |
| dc.type.journalArticle | Article | - |
| dc.subject.keywordPlus | NEURAMINIDASE INHIBITORS | - |
| dc.subject.keywordPlus | INFLUENZA | - |
- Appears in Collection
- CH-Journal Papers(저널논문)
- Files in This Item
- There are no files associated with this item.
This item is cited by other documents in WoS
| ⊙ Detail Information in WoSⓡ | Click to see |  |
| ⊙ Cited 231 items in WoS | Click to see citing articles in |  |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.